False Claims Act, Qui Tam and Litigation
We have extensive experience defending clients in qui tam and False Claims Act investigations and lawsuits. Our clients are companies and executives in a wide variety of industries, including large healthcare companies, educational institutions, and major defense and government contractors.
Our lawyers include former Department of Justice trial attorneys as well as long-time defense practitioners who understand the unique aspects of False Claims Act litigation. Because False Claims Act and private qui tam actions often arise amid multiple government investigations, we coordinate closely with our attorneys in our government investigations, white collar defense, government contracts, and healthcare practices to develop strategies that address the complex issues that arise in these parallel proceedings. These include conducting internal investigations, persuading the government not to institute an action or intervene in a pending qui tam suit, and defending clients in parallel criminal investigations or government debarment proceedings. When a False Claims Act lawsuit is unsealed, we have the experience to successfully defend it, and we have obtained numerous dismissals of False Claims Act cases in the early stages of the litigation.
From the outset of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) engaged in policymaking at a blistering speed compared to its historically measured pace. Robert Califf, who previously led the agency under Obama, was recently confirmed as FDA commissioner, and Califf’s approach to agency guidance will be closely monitored by many stakeholders. With two COVID-19 [...]
